CAMLINFINE
Camlin Fine Sciences Limited
Basic Materials · Specialty Chemicals
Market price data is delayed by at least 15 minutes. Not for trading or investment decisions.
Fundamentals
Current Price
₹103.61
P/B Ratio
2.18
52W High
₹333.3
52W Low
₹96.21
Dividend Yield
—
Profit Margin
-3.45%
ROE
—
Debt / Equity
0.73
Sector
Basic Materials
Industry
Specialty Chemicals
Peer Comparison same NSE industry · top 10 by 1M return
Chemicalsas of 8 Apr 2026 close
| Symbol | Company | Price | P/B | RSI | 1M Ret | ROE | D/E |
|---|---|---|---|---|---|---|---|
| CAMLINFINEyou | Camlin Fine Sciences Limited | ₹109.39 | 2.30 | 30.1 | -18.5% | — | 0.78 |
| BODALCHEM | Bodal Chemicals Limited | ₹64.64 | 0.73 | 78.4 | +46.8% | — | 0.77 |
| NACLIND | NACL Industries Limited | ₹166.7 | 7.36 | 78.6 | +41.5% | — | 1.13 |
| GUJALKALI | Gujarat Alkalies and Chemica | ₹587.6 | 0.77 | 75.3 | +36.8% | — | 0.06 |
| STALLION | Stallion India Fluorochemica | ₹135.17 | 3.42 | 67.7 | +32.7% | — | 0.00 |
| PRIMO | Primo Chemicals Limited | ₹22.27 | 1.37 | 76.4 | +30.4% | — | 0.41 |
| NOCIL | NOCIL Limited | ₹165.12 | 1.55 | 70.1 | +25.6% | — | 0.01 |
| HINDCON | Hindcon Chemicals Limited | ₹23.17 | 1.60 | 69.5 | +24.9% | — | 0.11 |
| KRONOX | Kronox Lab Sciences Limited | ₹136.72 | 4.95 | 69.6 | +24.3% | — | 0.03 |
| VIKASLIFE | Vikas Lifecare Limited | ₹1.59 | 0.43 | 68.1 | +18.7% | — | 0.14 |
| SEYAIND | Seya Industries Limited | ₹10.79 | 0.03 | 83.2 | +17.8% | — | 0.94 |
Price Chart
Quarterly Results Last 4 quarters
| Metric | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|
| Revenue | ₹457.2 Cr | ₹459.8 Cr | ₹423.6 Cr | ₹383.3 Cr |
| Gross Profit | ₹209.2 Cr | ₹213.1 Cr | ₹186.7 Cr | ₹166.6 Cr |
| Operating Income | ₹128.7 Cr | ₹17.4 Cr | ₹2.1 Cr | ₹86.6 Cr |
| Net Income | ₹-36.2 Cr | ₹-14.4 Cr | ₹-10.0 Cr | ₹-0.7 Cr |
Values in INR Crore. Source: yfinance / NSE filings.
SWOT Analysis AI · news + fundamentals
SWOT not available.
Recent News Sentiment
No recent news for this stock.
Data sourced from yfinance and public NSE filings. Not investment advice.